VAMED AG:企業の戦略・SWOT・財務情報

◆英語タイトル:VAMED AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9118
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

VAMED AG – Strategy, SWOT and Corporate Finance Report
Summary

VAMED AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

VAMED AG (Vamed) a subsidiary of Fresenius Proserve Gmbh, is a construction and engineering company. It offers a wide range of services including project development, planning, facility management, construction, project management, equipment supply, financial engineering, re-engineering, consulting services, and installing medical equipment. The company also provides logistics and procurement, medical technology management, technical operation, total operational management, training programs and quality management services and IT solutions. The company provides its services to healthcare sector including nursing, acute care, healthcare tourism, health prevention, health treatment, and rehabilitation facilities. The company has operations in several countries across Europe, Africa, the Middle East, Latin America, Oceania and Asia. Vamed is headquartered in Vienna, Austria.

Scope

- Detailed information on VAMED AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting VAMED AG in the form of a SWOT analysis
- An in-depth view of the business model of VAMED AG including a breakdown and examination of key business segments
- Intelligence on VAMED AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about VAMED AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of VAMED AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess VAMED AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on VAMED AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
VAMED AG: Company Overview 8
VAMED AG: Overview and Key Facts 8
VAMED AG: Overview 8
VAMED AG: Key Facts 8
VAMED AG: Key Employees 9
VAMED AG: Major Products and Services 10
VAMED AG: Company History 11
VAMED AG: Management Statement 12
VAMED AG: Locations and Subsidiaries 14
VAMED AG: Key Competitors 16
VAMED AG: Company Analysis 17
VAMED AG: Business Description 17
VAMED AG: SWOT Analysis 18
VAMED AG: SWOT Overview 18
VAMED AG: Strengths 18
VAMED AG: Weaknesses 19
VAMED AG: Opportunities 19
VAMED AG: Threats 20
VAMED AG: Corporate Financial Deals Activity 21
VAMED AG: Financial Deals Overview 21
VAMED AG: Targets and Partners 23
VAMED AG: Top Deals 2014 – 2018YTD* 24
VAMED AG: Mergers and Acquisitions 25
VAMED AG: Divestments 26
VAMED AG: Recent Developments 27
VAMED AG: News and Events Summary 27
VAMED AG: Business Expansion 29
VAMED AG: Regulatory and Legal Events 29
VAMED AG: Strategy and Operations 30
Appendix 33
Contact Us 33
Methodology 33
About MarketLine 34

List of Tables
Table 1: VAMED AG: Key Facts
Table 2: VAMED AG: Key Employees
Table 3: VAMED AG: Company History
Table 4: VAMED AG: Locations and Subsidiaries
Table 5: VAMED AG: Key Competitors
Table 6: VAMED AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: VAMED AG: M&A Activity by Geography (TTM*)
Table 8: VAMED AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: VAMED AG: Targets and Partners
Table 10: VAMED AG: Top Deals 2014 - 2018YTD*
Table 11: VAMED AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: VAMED AG: M&A Activity by Geography (2014 - YTD*2018)
Table 13: VAMED AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: VAMED AG: Divestments by Geography (2014 - YTD*2018)
Table 15: VAMED AG: News and Events Summary
Table 16: VAMED AG: Business Expansion
Table 17: VAMED AG: Regulatory and Legal Events
Table 18: VAMED AG: Strategy and Operations

List of Figures
Figure 1: VAMED AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: VAMED AG: M&A Activity by Geography (TTM*)
Figure 3: VAMED AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: VAMED AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: VAMED AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: VAMED AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 7: VAMED AG: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[VAMED AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sigma Pharmaceuticals Limited:戦略・SWOT・企業財務分析
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • X4 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a pharmaceutical company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiency disease. It also de …
  • Flexera Software LLC:企業の戦略的SWOT分析
    Flexera Software LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • S2Medical AB:製品パイプライン分析
    Summary S2Medical AB (S2Medical) is a medical technology company that designs, develops and markets wound dressings and products to treat burns and chronic ulcers. The company’s product portfolio consists of wound dressing patches; blood stilling synthetic epithelium dressing to control capillary bl …
  • Acadia Healthcare Company Inc:企業のM&A・事業提携・投資動向
    Acadia Healthcare Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acadia Healthcare Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Kansai Paint Co Ltd (4613):企業の財務・戦略的SWOT分析
    Kansai Paint Co Ltd (4613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Spineology Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spineology Inc (Spineology) is a medical device company that develops and designs spinal implants. The company offers products such as pedicular fixation system, interbody fusion system, deployable grafting system, amniotic fixation system, allografts, retractor system, liquid tissue matrix, …
  • Teco Energy Inc:電力:M&Aディール及び事業提携情報
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …
  • Westlake Chemical Corp (WLK):企業の財務・戦略的SWOT分析
    Summary Westlake Chemical Corp (Westlake Chemical) is a manufacturer and supplier of petrochemicals, polymers and building products. The company offers products such as olefins, vinyls, styrene, polyethylene and epolene polymers. Westlake Chemical manufactures petrochemicals through olefins business …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ERG Power Generation SpA:企業の戦略的SWOT分析
    ERG Power Generation SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) operates as a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cem …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • Ashley Furniture Industries Inc:企業の戦略・SWOT・財務分析
    Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Fujifilm SonoSite Inc:企業の戦略的SWOT分析
    Fujifilm SonoSite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Goodwin Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd, is a biological contract development and manufacturing organization that offers antibody drug conjugates, radioimmunoconjugates, and other protein bioconjugates. The organization offers cell culture, purificati …
  • Macquarie Group Ltd:戦略・SWOT・企業財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Laboratoires Pierre Fabre SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆